Spanish blood plasma company stock tumbles after short-seller research report

Spanish blood plasma company Grifols saw its shares plunge more than 40% at one point on Tuesday after hedge fund Gotham City Research questioned the Madrid-listed group’s financial reporting.

Previous post U.S. trade deficit narrows 2% to $63.2 billion. GDP may get a lift.
Next post As CEO departs, Twilio investors should prepare for more changes — and a possible sale